期刊
NURSING CLINICS OF NORTH AMERICA
卷 52, 期 1, 页码 65-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cnur.2016.10.004
关键词
Monoclonal antibody; Nanoparticle albumin-bound drug; Tyrosine kinase inhibitor; Immunomodulatory drug; Proteasome inhibitor; Cancer therapeutics; Targeted therapy; Nursing care
类别
Cancer therapeutics has been growing in an unprecedented fashion and has evolved rapidly in the past two decades. Specific gene mutation, protein dysfunction and dysregulation, intracellular signaling pathways, and immune modulation have been targeted. These therapeutic advances came largely because of improved understanding of the pathobiology of cancer at the genetic and molecular levels. This article addresses the need of novice nurses for cancer treatment related information and evidence -based nursing care of patients diagnosed with cancer while undergoing novel and breakthrough therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据